North America Genomics Market By Product & Service (Consumables, Systems & Software and Services), By Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others), By End User (Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others), By Technology (Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
The North America Genomics Market would witness market growth of 17.3% CAGR during the forecast period (2021-2027).
Genomics has been scientifically demonstrated to be effective in disease prevention, management, and therapy. Over the last few years, the healthcare environment has shifted from traditional treatment methods to precision medicine, and this movement has been accelerated by extraordinary clinical qualities. Whole-genome sequencing has emerged as a valuable tool for diagnosing life-threatening disorders like cancer.
The ongoing trends of the market are the expanding government support and increased number of genomics studies, reducing sequencing costs, and more genomics applications. The genomics industry is expected to increase at an exponential rate due to important genetic advances and their applications in a variety of fields, including intragenomic phenomena such as epistasis, heterosis, pleiotropy, and other correlations between alleles and locations inside the genome. Bioengineering and synthetic biology applications are expected to play a key role in boosting the growth of the genomics market.
North America is witnessing a massive adoption of new sequencing technology and a shift toward tailored medications. In addition, government assistance is critical. For example, the Biden Administration announced a USD 1.7 billion investment to Fight COVID-19 Variants in April 2021, with USD 1 billion going to expand genomic sequencing and USD 400 million going to support innovation initiatives like the launch of new innovative centers of excellence in genomic epidemiology.
The US market dominated the North America Genomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $19,989 million by 2027. The Canada market is expected to witness a CAGR of 20% during (2021 - 2027). Additionally, The Mexico market would experience a CAGR of 18.9% during (2021 - 2027).
Based on Product & Service, the market is segmented into Consumables, Systems & Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on Technology, the market is segmented into Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product & Service
- Consumables
- Systems & Software and
- Services
- Drug Discovery & Development
- Diagnostics
- Agriculture & Animal Research and
- Others
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Pharmaceutical & Biotechnology Companies and
- Others
- Sequencing
- PCR
- Nucleic Acid Extraction & Purification
- Microarray, and
- Others
- US
- Canada
- Mexico
- Rest of North America
- Creative Biogene
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Eurofins Scientific Group
- Qiagen N.V.
- New England BioLabs, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Genomics Market, by Product & Service
- 1.4.2 North America Genomics Market, by Application
- 1.4.3 North America Genomics Market, by End User
- 1.4.4 North America Genomics Market, by Technology
- 1.4.5 North America Genomics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players
- Chapter 4. North America Genomics Market by Product & Service
- 4.1 North America Consumables Market by Country
- 4.2 North America Systems & Software Market by Country
- 4.3 North America Services Market by Country
- Chapter 5. North America Genomics Market by Application
- 5.1 North America Drug Discovery & Development Market by Country
- 5.2 North America Diagnostics Market by Country
- 5.3 North America Agriculture & Animal Research Market by Country
- 5.4 North America Others Market by Country
- Chapter 6. North America Genomics Market by End User
- 6.1 North America Hospitals & Clinics Market by Country
- 6.2 North America Research Centers and Academic & Government Institutes Market by Country
- 6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
- 6.4 North America Others Market by Country
- Chapter 7. North America Genomics Market by Technology
- 7.1 North America Sequencing Market by Country
- 7.2 North America PCR Market by Country
- 7.3 North America Nucleic Acid Extraction & Purification Market by Country
- 7.4 North America Microarray Market by Country
- 7.5 North America Others Market by Country
- Chapter 8. North America Genomics Market by Country
- 8.1 US Genomics Market
- 8.1.1 US Genomics Market by Product & Service
- 8.1.2 US Genomics Market by Application
- 8.1.3 US Genomics Market by End User
- 8.1.4 US Genomics Market by Technology
- 8.2 Canada Genomics Market
- 8.2.1 Canada Genomics Market by Product & Service
- 8.2.2 Canada Genomics Market by Application
- 8.2.3 Canada Genomics Market by End User
- 8.2.4 Canada Genomics Market by Technology
- 8.3 Mexico Genomics Market
- 8.3.1 Mexico Genomics Market by Product & Service
- 8.3.2 Mexico Genomics Market by Application
- 8.3.3 Mexico Genomics Market by End User
- 8.3.4 Mexico Genomics Market by Technology
- 8.4 Rest of North America Genomics Market
- 8.4.1 Rest of North America Genomics Market by Product & Service
- 8.4.2 Rest of North America Genomics Market by Application
- 8.4.3 Rest of North America Genomics Market by End User
- 8.4.4 Rest of North America Genomics Market by Technology
- Chapter 9. Company Profiles
- 9.1 Creative Biogene
- 9.1.1 Company Overview
- 9.2 Thermo Fisher Scientific, Inc.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.6 SWOT Analysis
- 9.3 Illumina, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.5.2 Acquisition and Mergers:
- 9.4 Bio-Rad laboratories, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Acquisition and Mergers:
- 9.5 Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Acquisition and Mergers:
- 9.6 Agilent Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.5.2 Product Launches and Product Expansions:
- 9.6.5.3 Acquisition and Mergers:
- 9.7 F. Hoffmann-La Roche Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.5.2 Product Launches and Product Expansions:
- 9.7.5.3 Acquisition and Mergers:
- 9.8 Eurofins Scientific Group
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Recent strategies and developments:
- 9.8.4.1 Acquisition and Mergers:
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.5.2 Product Launches and Product Expansions:
- 9.9.5.3 Acquisition and Mergers:
- 9.10. New England BioLabs, Inc.
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
- 9.10.2.1 Product Launches and Product Expansions:
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook